West Pharmaceutical Services, Inc. Class Action: Levi & Korsinsky Reminds West Pharmaceutical Services Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 7, 2025 - WST

Published: 2025-06-27 09:37:14 ET WST

Published on 06/27/2025 at 09:37

NEW YORK - June 27, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=154148&wire=56

WST investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (b) Wests SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Companys profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Companys exit from continuous glucose monitoring contracts with longstanding customers; and (d) as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis.

WHAT'S NEXT? If you suffered a loss in West Pharmaceutical Services, Inc. during the relevant time frame, you have until July 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To learn more about this case, subscribe to the Bulls & Betrayals podcast, which features a dedicated episode unpacking the allegations against West Pharmaceutical Services, Inc.. Listen now and find out if you are eligible to join the lawsuit.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 17th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

View the original release on www.newmediawire.com